Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Cancer Chemother Pharmacol ; 42(4): 313-8, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9744777

RESUMO

PURPOSE: These studies sought to evaluate the biochemical and cellular pharmacokinetic properties, cytotoxicity and antitumor efficacy of a new analogue of 10-deaza-aminopterin (PDX) against human tumors. METHODS: Studies were conducted with a group of human tumor cell lines in culture examining PDX and other folate analogues as permeants for mediated membrane transport, as inhibitors of dihdrofolate reductase and as substrates for folylpolyglutamate synthetase. These same analogues were examined for their cytotoxicity following a 3-h pulse exposure, in experiments providing a value for IC50. Other studies with these analogues were conducted in nude mice bearing subcutaneously implanted human tumors. Treatment of the mice was initiated 4 days after implantation of the tumor using a schedule of administration of one dose per day for 5 days. The tumors were measured 6 days after cessation of therapy and compared to controls for assessment of response. RESULTS: In the CCRF-CEM cell system, PDX was 2- to 3-fold less effective as an inhibitor of dihydrofolate reductase than aminopterin (AMT), methotrexate (MTX) or edatrexate (EDX) but much more effective as a permeant for one-carbon, reduced folate transport inward (PDX > AMT approximately equal to EDX > MTX) and substrate for folylpolyglutamate synthetase (PDX > AMT > EDX > MTX). As predicted by these results, PDX was 15- to 40-fold more cytotoxic than MTX and 3- to 4-fold more cytotoxic than the highly potent EDX following a 3-h pulse exposure in culture of CCRF-CEM cells and cells from a panel of three human breast and two human nonsmall-cell (NSC) lung cancers. The same relative differences were shown for the therapeutic efficacy of these three analogues at equitoxic doses in studies with the human MX-1 and LX-1 tumors and the human A549 NSC lung tumor xenografted in nude mice. On a schedule of qd x 5 given 3-4 days posttransplant, MTX was minimally active (modest tumor growth delay) against all three tumors. EDX was highly active (25-35% complete regressions and 5-10% cures) against the MX-1 and LX-1 tumors but very modestly active (no regressions) against the A549 tumor. In contrast, PDX was even more active (75-85% complete regressions and 25-30% cures) than EDX against the MX-1 and LX-1 tumors and highly active (30% complete regressions and 20% cures) against the A549 tumor. CONCLUSIONS: These studies showed significantly enhanced antitumor properties of PDX compared with MTX and EDX. Based upon these results, clinical trials of PDX in patients with metastatic breast and NSC lung cancer appear to be warranted.


Assuntos
Aminopterina/análogos & derivados , Antineoplásicos/farmacologia , Antagonistas do Ácido Fólico/farmacologia , Aminopterina/química , Aminopterina/farmacologia , Animais , Antineoplásicos/farmacocinética , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Inibidores Enzimáticos/farmacocinética , Inibidores Enzimáticos/farmacologia , Antagonistas do Ácido Fólico/farmacocinética , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Metotrexato/farmacologia , Camundongos , Camundongos Nus , Relação Estrutura-Atividade , Especificidade por Substrato , Tetra-Hidrofolato Desidrogenase/metabolismo , Células Tumorais Cultivadas
2.
J Med Chem ; 40(15): 2386-97, 1997 Jul 18.
Artigo em Inglês | MEDLINE | ID: mdl-9240353

RESUMO

The pentapeptide, thymopentin (Arg1-Lys2-Asp3-Val4-Tyr5) is known for its activity as an immunomodulating drug, but with limited half-life in plasma. In this first paper of a series of three studies, the synthesis of analogs stabilized at the peptide bond between the C-terminal amino acids via insertion of a ketomethylene moiety is described. N-Blocked pseudopeptides containing Val(k)Phe, Ala(k)Phe, and Val(k)Val units were prepared and attached to chloromethyl Merrifield resin via the carboxy terminal. Removal of the N-BOC group by trifluoroacetic acid was followed by sequential coupling with N-BOC dipeptides of aspartic acid to yield resin-bound N-BOC pseudotetrapeptides. Removal of N-BOC and coupling with N-BOC-r-N-tosylarginine followed by total cleavage of blocking groups and resin by HF afforded the target pseudopentapeptides. The analogs were found to compete favorably with thymopentin for binding to CEM cells, but binding was reduced by about 20-30% on average. All analogs showed significant enhancement of half-life versus thymopentin in mouse serum, but most showed only modest improvement in human serum. Insertion of proline or norleucine at position 2 in the chain caused a substantial increase in half-life (3-4-fold), while N-methylnorleucine conferred complete stability in the analogs.


Assuntos
Adjuvantes Imunológicos/química , Cetonas/química , Oligopeptídeos/química , Timopentina/análogos & derivados , Adjuvantes Imunológicos/sangue , Adjuvantes Imunológicos/farmacologia , Animais , Linhagem Celular , Meia-Vida , Humanos , Espectroscopia de Ressonância Magnética , Camundongos , Ensaio Radioligante , Espectrometria de Massas de Bombardeamento Rápido de Átomos , Relação Estrutura-Atividade , Timopentina/sangue , Timopentina/farmacologia
3.
J Med Chem ; 40(3): 370-6, 1997 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-9022804

RESUMO

Carbonation of the dianions (LDA) of 5-methylthiophene-2-carboxylic, 2-methylpyridine-5-carboxylic, and 3-methylpyridine-6-carboxylic acids provided the respective carboxy heteroarylacetic acids. The crude diacids were directly esterified in MeOH-HCl to afford the diesters. Alkylation of the sodio anions with ethyl iodide yielded the appropriate alpha-ethyl diesters. The anions of the various diester substrates were then alkylated by 2,4-diamino-6-(bromomethyl)-pteridine followed by ester saponification at room temperature to afford the respective 2,4-diamino-4-deoxy-10-carboxy-10-deazapteroic acids. The 10-carboxyl group was readily decarboxylated by heating in DMSO at temperatures of 110-135 degrees C to give the diamino 10-deaza heteropteroic acid intermediates. Coupling with diethyl L-glutamate followed by ester hydrolysis afforded the target aminopterins. The analogues were evaluated for antiinflammatory effect in the mouse type II collagen model. The thiophene analogue of 10-ethyl-10-deazaaminopterin was found to be an effective inhibitor in terms of reduced visual evidence of inflammation and swelling as determined by caliper measurement.


Assuntos
Antirreumáticos/uso terapêutico , Artrite Reumatoide/tratamento farmacológico , Metotrexato/análogos & derivados , Aminopterina , Animais , Antirreumáticos/síntese química , Antirreumáticos/química , Antirreumáticos/farmacologia , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Colágeno , Humanos , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Metotrexato/química , Metotrexato/farmacologia , Metotrexato/uso terapêutico , Camundongos , Estrutura Molecular , Células Tumorais Cultivadas
4.
J Med Chem ; 40(3): 377-84, 1997 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-9022805

RESUMO

Twenty-six compounds derived from the 5-deaza- and 5,10-dideazaaminopterin series of aminopterin analogues were evaluated for antiarthritic activity in the mouse type II collagen model. New compounds in the 5-deaza series were prepared by alkylation of an appropriate N-substituted (4-aminobenzoyl)-L-glutamic acid dialkyl ester or N-(5-amino-2-thenoyl)-L-glutamate diester with a 2,4-diamino-5-alkyl-6-(bromomethyl)-5-deazapteridine. The resultant 5-deazaaminopterin diesters were saponified to provide the target 5-deaza analogues. 5,10-Dideazaaminopterins were synthesized by similar alkylation of the carbanions of appropriate 4-carboxyphenylacetic, (5-carboxy-2-thienyl)acetic, or (5-carboxy-2-pyridyl)acetic acid dimethyl esters. The diesters of the 2,4-diamino-4-deoxy-10-carboxy-5,10-dideazapteroic acid types so obtained were saponified and then readily decarboxylated by heating in Me2SO solution to provide the 2,4-diamino-5,10-dideazapteroic acid-type intermediates. Peptide coupling with diethyl L-glutamate followed by ester hydrolysis at room temperature afforded the new 5,10-dideazaaminopterin analogues. 5-Deazaaminopterins bearing an alkyl substituent at the 5-position were generally quite effective as antiinflammatory agents. Thus 5-propyl-5-deazaaminopterin, 5-methyl-10-propargyl-5-deazaaminopterin, 5-methyl-10-allyl-5-deazaaminopterin, 5-ethyl-5-deazamethotrexate, and 2,5-disubstituted thiophene analogue of 5-methyl-5-deazaaminopterin showed potencies greater than methotrexate by intraperitoneal or oral administration and were active over a considerably broader dose range. Useful activity in the 5,10-dideaza series was only observed for 5,10-dideazaaminopterin and its 10-methyl analogue. Alkyl substitution at C-5 or C-10 was generally detrimental to antiinflammatory activity in this series.


Assuntos
Aminopterina/análogos & derivados , Antirreumáticos/uso terapêutico , Artrite Reumatoide/tratamento farmacológico , Metotrexato/análogos & derivados , Aminopterina/síntese química , Aminopterina/química , Aminopterina/farmacologia , Aminopterina/uso terapêutico , Animais , Antirreumáticos/síntese química , Antirreumáticos/química , Antirreumáticos/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Colágeno , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Metotrexato/farmacologia , Metotrexato/uso terapêutico , Camundongos , Camundongos Endogâmicos DBA , Estrutura Molecular , Células Tumorais Cultivadas
5.
J Med Chem ; 36(15): 2228-31, 1993 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-8340923

RESUMO

Successive alkylation of dimethyl homoterephthalate with propargyl bromide and 2,4-diamino-6-(bromomethyl)pteridine followed by ester saponification at room temperature afforded 2,4-diamino-4-deoxy-10-carboxy-10-propargyl-10-deazapteroic acid. The 10-COOH was readily decarboxylated by heating in DMSO at a temperature of only 120 degrees C to yield the diamino-10-propargyl-10-deazapteroic acid intermediate. Coupling with diethyl L-glutamate and ester hydrolysis gave the title compound. The 10-propargyl analogue was about 5 times more potent than MTX as an inhibitor of growth in L1210 cells, but was only one-third as potent as an inhibitor of DHFR from L1210. The analogue was transported inward very effectively in L1210 cells showing a 10-fold advantage over MTX. At a dose of 36 mg/kg the 10-propargyl compound caused shrinkage of the E0771 solid murine mammary tumor to only 1% of untreated controls.


Assuntos
Aminopterina/análogos & derivados , Antineoplásicos/síntese química , Aminopterina/uso terapêutico , Animais , Feminino , Leucemia L1210/tratamento farmacológico , Neoplasias Mamárias Experimentais/tratamento farmacológico , Camundongos , Relação Estrutura-Atividade
6.
J Med Chem ; 35(2): 320-4, 1992 Jan 24.
Artigo em Inglês | MEDLINE | ID: mdl-1732549

RESUMO

2-Carbomethoxy-4-(p-carbomethoxyphenyl)cyclohexanone was prepared in a four-step process and thermally condensed with 2,4,6-triaminopyrimidine to afford methyl 2,4-diamino-4-deoxy-7-hydroxy-5,10-ethano-5,10-dideazapteroate+ ++. Reduction of the 7-oxo function with borane gave the 7,8-dihydro pterin which was subsequently oxidized to the fully aromatic pteroate ester with dicyanodichlorobenzoquinone. Saponification of the benzoate ester, coupling with diethyl glutamate and final ester hydrolysis afforded the title compound. This novel deazaaminopterin analogue was approximately as potent as methotrexate in vitro in terms of DHFR and L1210 cell growth inhibition. There are indications of diastereomeric differences in the enzyme inhibition measurements. A significant transport advantage over MTX for influx into L1210 cells was observed. The compound was active against the E 0771 murine mammary solid tumor, but further investigation with individual diastereomers is required to define the ED50.


Assuntos
Aminopterina/análogos & derivados , Antagonistas do Ácido Fólico/síntese química , Aminopterina/síntese química , Aminopterina/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , Antagonistas do Ácido Fólico/farmacologia , Leucemia L1210/enzimologia , Leucemia L1210/patologia , Neoplasias Mamárias Experimentais/tratamento farmacológico , Metotrexato/farmacologia , Camundongos , Células Tumorais Cultivadas/efeitos dos fármacos
7.
J Med Chem ; 31(1): 150-3, 1988 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3121855

RESUMO

The syntheses of 8-deazahomofolic acid and its tetrahydro derivative, potential inhibitors of thymidylate synthase (TS) and other folate related enzymes, are described. Wittig condensation of 2-acetamido-6-formyl-4-pyrimidinol with the triphenylphosphine ylide 3 derived from N-acetyl-4-(p-carbethoxyanilino)-1-chloro-2-butanone, hydrogenation of the enone intermediate 5, introduction of a 5-amino group via diazonium coupling, and reductive ring closure yielded ethyl N11-acetyl-8-deazahomopteroate (8). Alkaline hydrolysis gave 8-deazahomopteroic acid, which was blocked as the 11-trifluoroacetyl derivative, coupled with diethyl L-glutamate, and the blocking groups saponified to afford 8-deazahomofolic acid (12). Hydrogenation of the glutamate diester intermediate and subsequent saponification yielded the tetrahydro-8-deazahomofolate (14). Growth inhibition of Streptococcus faecium, Lactobacillus casei, and L1210 cells in culture by the target compounds was modest. They were also weak inhibitors of thymidylate synthase, dihydrofolate reductase, glycinamide-ribonucleotide transformylase, and aminoimidazolecarboxamide ribonucleotide transformylase. In contrast, 8-deazafolate showed moderate inhibition of aminoimidazolecarboxamide ribonucleotide transformylase, suggesting that inhibition of this enzyme may be related to its cytotoxic action. Tetrahydro-8-deazahomofolate showed low substrate activity with thymidylate synthase.


Assuntos
Antibacterianos/síntese química , Ácido Fólico/análogos & derivados , Hidroximetil e Formil Transferases , Tetra-Hidrofolatos/síntese química , Aciltransferases/antagonistas & inibidores , Animais , Ácido Fólico/síntese química , Ácido Fólico/farmacologia , Ácido Fólico/uso terapêutico , Antagonistas do Ácido Fólico , Indicadores e Reagentes , Lacticaseibacillus casei/efeitos dos fármacos , Leucemia L1210/tratamento farmacológico , Camundongos , Testes de Sensibilidade Microbiana , Fosforribosilaminoimidazolcarboxamida Formiltransferase , Fosforribosilglicinamido Formiltransferase , Streptococcus/efeitos dos fármacos , Relação Estrutura-Atividade , Tetra-Hidrofolatos/farmacologia , Tetra-Hidrofolatos/uso terapêutico , Timidilato Sintase/antagonistas & inibidores
8.
FEBS Lett ; 217(1): 106-10, 1987 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-3109940

RESUMO

The binding of folate to Lactobacillus casei dihydrofolate reductase in the presence and absence of NADP+ has been studied by 15N NMR, using [5-15N]folate. In the presence of NADP+, three separate signals were observed for the single 15N atom, in agreement with our earlier evidence from 1H and 13C NMR for multiple conformations of this complex [(1982) Biochemistry 21, 5831-5838]. The 15N spectra of the binary enzyme-folate complex provide evidence for the first time that this complex also exists in at least two conformational states. This is confirmed by the observation of two separate resonances for the 7-proton of bound folate, located by two-dimensional exchange spectroscopy.


Assuntos
Proteínas de Bactérias/metabolismo , Ácido Fólico/metabolismo , Tetra-Hidrofolato Desidrogenase/metabolismo , Concentração de Íons de Hidrogênio , Lacticaseibacillus casei/enzimologia , Espectroscopia de Ressonância Magnética , NADP/metabolismo , Ligação Proteica , Conformação Proteica
9.
J Med Chem ; 29(9): 1786-9, 1986 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-3091834

RESUMO

The synthesis of the 5,10-methylene analogue of 5,6,7,8-tetrahydro-8,10-dideazaminopterin, a potential dual inhibitor of dihydrofolate reductase (DHFR) and thymidylate synthase (TS) enzymes, is described. The dimethyl ester of 10-carboxy-4-amino-4-deoxy-8,10-dideazapteroic acid was converted to the tetrahydro derivative by hydrogenation. Thermally induced cyclization of the 10-carbomethoxy and the 5-NH groups afforded the 5,10-carbonyl analogue. Reduction of the lactam with borane readily yielded the key 5,10-methylene-4-amino-4-deoxy-8,10-dideazatetrahydropteroic acid methyl ester. Saponification of the benzoate ester and coupling with L-glutamate concluded the synthesis. The title compound was a modest inhibitor of growth in folate-dependent bacteria. Streptococcus faecium and Lactobacillus casei, but inhibition of DHFR or TS derived from L. casei was poor. The compound was also a weak inhibitor of DHFR derived from L1210 murine leukemia and was a weak inhibitor of L1210 growth in culture.


Assuntos
Aminopterina/análogos & derivados , Antagonistas do Ácido Fólico/farmacologia , Aminopterina/síntese química , Aminopterina/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , Fenômenos Químicos , Química , Lacticaseibacillus casei/efeitos dos fármacos , Lacticaseibacillus casei/crescimento & desenvolvimento , Leucemia L1210/enzimologia , Leucemia L1210/patologia , Metotrexato/farmacologia , Camundongos , Streptococcus/efeitos dos fármacos , Streptococcus/crescimento & desenvolvimento , Timidilato Sintase/antagonistas & inibidores
10.
Prostaglandins ; 16(3): 451-9, 1978 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-725077

RESUMO

Prostaglandins PGE2, PGE1, PGF2alpha, and PGE1 substantially increase automaticity in SA-nodal, right atrial preparations excised from guinea pigs. This natural pacemaker tissue is sensitive to nanomolar doses of PG with, for example, 10(-8) M PGE2, increasing SA rate by about 20%. If these preparations are pretreated with 2 micrometer indomethacin, a blocker of endogenous prostaglandin synthesis, then spontaneous rate drops and subsequent rate increases due to PGE2 administration can be more easily demonstrated. Guinea pig pacemaker tissue differs from similar rabbit tissue not only in that it is directly responsive to PGE2, but also in that PGE2 does not depress the absolute response to transmural stimulation (adrenergically mediated rate increase). The positive chronotropic responses to PGE2 also occur when the guinea pig tissue is pretreated in 0.6 micrometer propranolol, which causes blockade of beta-adrenergic receptors. The pacemaker myocardium in the guinea pigs thus appears to be directly stimulated by exogenous PGE2 at very low doses. The observation that 2 micrometer indomethacin reduces SA-nodal rate suggests the presence of a very sensitive, functionally important, PGE-like system which modulates heart rate in this mammalian species.


Assuntos
Prostaglandinas/farmacologia , Nó Sinoatrial/efeitos dos fármacos , Animais , Cobaias , Indometacina/farmacologia , Norepinefrina/farmacologia , Propranolol/farmacologia , Antagonistas de Prostaglandina/farmacologia , Prostaglandinas A/administração & dosagem , Prostaglandinas A/farmacologia , Prostaglandinas E/administração & dosagem , Prostaglandinas E/farmacologia , Prostaglandinas F/administração & dosagem , Prostaglandinas F/farmacologia , Coelhos
14.
s.l; s.n; 1974. 2 p. tab, graf.
Não convencional em Inglês | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1233854

Assuntos
Hanseníase
15.
s.l; s.n; 1974. 2 p. tab, graf.
Não convencional em Inglês | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1233858

Assuntos
Hanseníase
16.
s.l; s.n; 1974. 3 p. tab.
Não convencional em Inglês | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1234297

Assuntos
Hanseníase
18.
In. Annual Leprosy Research Conference, 7. Annual Leprosy Research Conference, 7/Abstracts. California, National Institute of Health, 1972. p.22.
Não convencional em Inglês | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1243366
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...